Compare Hinge Health Inc. Class A Common Stock (HNGE) vs LyondellBasell Industries NV (LYB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs LyondellBasell Industries NV — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while LyondellBasell Industries NV trades at $61.84 (market cap $19.76B). The key difference: LyondellBasell Industries NV is far larger — about 2.3× Hinge Health Inc. Class A Common Stock's market cap, and LyondellBasell Industries NV pays a 4.51% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and LyondellBasell Industries NV for 88 Days on average.
| HNGE | LYB | |
|---|---|---|
Market Cap | $8.47B | $19.76B |
Volume | 1,624,526 | 2,519,506 |
Sector | Health | Basic Materials |
52-Week High | $105.14 | $82.38 |
52-Week Low | $31.17 | $42.28 |
Typical Hold Time | 0 Days | 88 Days |
Enterprise Value | $8.09B | $31.35B |
Dividend Yield | — | 4.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
LYB trades at $60.01, up 1.01% on the day, with a bearish technical signal from moving averages but neutral oscillators. Revenue declined to $30.15B in 2025, with a net loss of $745M, though Q2 2026 EPS beat expectations at $4.30. The company maintains a dividend payout, with a consensus analyst price target of $68.56. Cash flow from operations improved to $2.26B in 2025, but debt-to-asset ratio rose to 38.18%.
Outlook is mixed: analyst consensus is evenly split between Buy and Hold, with potential upside to the price target, but risks include declining revenue, negative profit margins, and high debt. Recent news highlights dividend sustainability concerns in the chemical sector, though some analysts see earnings recovery potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About LyondellBasell Industries NV
LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →
